Rossella Rota

4.0k total citations
79 papers, 1.8k citations indexed

About

Rossella Rota is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rossella Rota has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Rossella Rota's work include Sarcoma Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (8 papers). Rossella Rota is often cited by papers focused on Sarcoma Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (8 papers). Rossella Rota collaborates with scholars based in Italy, United States and Spain. Rossella Rota's co-authors include Silvia Pomella, Franco Locatelli, Roberta Ciarapica, Angela Gallo, Xavier Xiol, José Castellote, Ricardo P. Garay, Lucio Miele, Patrick Hannaert and Sílvia Salord and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.

In The Last Decade

Rossella Rota

74 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rossella Rota Italy 27 1.2k 310 306 234 211 79 1.8k
Arianna Giacomini Italy 25 1.2k 1.1× 356 1.1× 224 0.7× 407 1.7× 106 0.5× 67 2.0k
Gang‐Hong Lee Japan 24 869 0.8× 341 1.1× 419 1.4× 444 1.9× 201 1.0× 104 1.8k
Juan A. Recio Spain 23 1.0k 0.9× 215 0.7× 296 1.0× 526 2.2× 133 0.6× 53 1.8k
Raphaël Saffroy France 27 559 0.5× 288 0.9× 343 1.1× 491 2.1× 330 1.6× 79 1.8k
Hervé Sartelet France 23 807 0.7× 377 1.2× 224 0.7× 527 2.3× 148 0.7× 82 1.7k
Sang‐Hyun Song South Korea 26 938 0.8× 187 0.6× 177 0.6× 382 1.6× 169 0.8× 79 1.7k
Harun M. Said Germany 26 886 0.8× 405 1.3× 166 0.5× 211 0.9× 159 0.8× 41 1.7k
Raffaele Longo Italy 19 567 0.5× 326 1.1× 297 1.0× 571 2.4× 120 0.6× 64 1.5k
Zhen Zhao United States 17 1.5k 1.3× 382 1.2× 130 0.4× 745 3.2× 193 0.9× 34 2.4k
Krzysztof Moroz United States 23 854 0.7× 584 1.9× 302 1.0× 429 1.8× 174 0.8× 72 1.8k

Countries citing papers authored by Rossella Rota

Since Specialization
Citations

This map shows the geographic impact of Rossella Rota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rossella Rota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rossella Rota more than expected).

Fields of papers citing papers by Rossella Rota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rossella Rota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rossella Rota. The network helps show where Rossella Rota may publish in the future.

Co-authorship network of co-authors of Rossella Rota

This figure shows the co-authorship network connecting the top 25 collaborators of Rossella Rota. A scholar is included among the top collaborators of Rossella Rota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rossella Rota. Rossella Rota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zwergel, Clemens, Giovanni Barillari, Cinzia Marchese, et al.. (2025). Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies. Drug Discovery Today. 30(12). 104516–104516.
3.
Adam, Elisabeth, et al.. (2025). A Comprehensive Protocol and Step-by-Step Guide for Multi-Omics Integration in Biological Research. Journal of Visualized Experiments. 1 indexed citations
4.
Condorelli, Angelo Giuseppe, Cristiano De Stefanis, Rossella Rota, et al.. (2024). Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology. 144(7). 1522–1533.e10. 2 indexed citations
5.
Riveiro‐Barciela, Mar, Ana Barreira‐Díaz, Paula Esteban García, et al.. (2024). Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver International. 44(9). 2303–2314. 11 indexed citations
6.
Pomella, Silvia, Rita Alaggio, Willemijn B. Breunis, et al.. (2023). Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. Cancers. 15(10). 2823–2823. 3 indexed citations
7.
Pomella, Silvia, Matteo Cassandri, Francesco Marampon, et al.. (2023). DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 24(3). 2673–2673. 11 indexed citations
8.
Pomella, Silvia, et al.. (2022). New Insights on the Nuclear Functions and Targeting of FAK in Cancer. International Journal of Molecular Sciences. 23(4). 1998–1998. 26 indexed citations
9.
Pomella, Silvia, Matteo Cassandri, Simona Camero, et al.. (2022). Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma. International Journal of Molecular Sciences. 23(21). 13281–13281. 2 indexed citations
10.
Camero, Simona, Matteo Cassandri, Silvia Pomella, et al.. (2022). Radioresistance in rhabdomyosarcomas: Much more than a question of dose. Frontiers in Oncology. 12. 1016894–1016894. 1 indexed citations
11.
Wang, Long, Prethish Sreenivas, Jiangfei Chen, et al.. (2021). SNAI2-Mediated Repression of BIM Protects Rhabdomyosarcoma from Ionizing Radiation. Cancer Research. 81(21). 5451–5463. 9 indexed citations
12.
Cassandri, Matteo, Silvia Pomella, Luisa Milazzo, et al.. (2021). MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells. International Journal of Molecular Sciences. 22(19). 10671–10671. 16 indexed citations
13.
Camero, Simona, Paola Pontecorvi, Simona Ceccarelli, et al.. (2021). DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma. Cells. 10(11). 2956–2956. 21 indexed citations
14.
Pomella, Silvia, et al.. (2020). FAK Signaling in Rhabdomyosarcoma. International Journal of Molecular Sciences. 21(22). 8422–8422. 7 indexed citations
15.
Stazi, Giulia, Rossella Fioravanti, Clemens Zwergel, et al.. (2020). Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells. ACS Medicinal Chemistry Letters. 11(5). 977–983. 59 indexed citations
16.
Gryder, Berkley E., Lei Wu, Girma M. Woldemichael, et al.. (2019). Chemical genomics reveals histone deacetylases are required for core regulatory transcription. Nature Communications. 10(1). 3004–3004. 98 indexed citations
17.
Hudlebusch, Heidi Rye, Julie Skotte, Eric Santoni‐Rugiu, et al.. (2011). MMSET Is Highly Expressed and Associated with Aggressiveness in Neuroblastoma. Cancer Research. 71(12). 4226–4235. 50 indexed citations
18.
Rota, Rossella, Roberta Ciarapica, Antonio Giordano, Lucio Miele, & Franco Locatelli. (2011). MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality. Molecular Cancer. 10(1). 120–120. 45 indexed citations
19.
Toschi, Elena, et al.. (2000). Wild-Type p53 Gene Transfer Inhibits Invasion and Reduces Matrix Metalloproteinase-2 Levels in p53-Mutated Human Melanoma Cells. Journal of Investigative Dermatology. 114(6). 1188–1194. 36 indexed citations
20.
Rota, Rossella, et al.. (1993). Cell volume regulation in rat thymocytes.. The Journal of Physiology. 465(1). 403–414. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026